Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Polymyositis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Immunosuppressant
1.2.3 Alkylating Agent
1.2.4 Immunoglobulin
1.2.5 Monoclonal Antibodies
1.2.6 Corticosteroids
1.3 Market by Application
1.3.1 Global Polymyositis Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Polymyositis Treatment Market Perspective (2018-2033)
2.2 Polymyositis Treatment Growth Trends by Region
2.2.1 Global Polymyositis Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Polymyositis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Polymyositis Treatment Forecasted Market Size by Region (2024-2033)
2.3 Polymyositis Treatment Market Dynamics
2.3.1 Polymyositis Treatment Industry Trends
2.3.2 Polymyositis Treatment Market Drivers
2.3.3 Polymyositis Treatment Market Challenges
2.3.4 Polymyositis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Polymyositis Treatment Players by Revenue
3.1.1 Global Top Polymyositis Treatment Players by Revenue (2018-2023)
3.1.2 Global Polymyositis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Polymyositis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Polymyositis Treatment Revenue
3.4 Global Polymyositis Treatment Market Concentration Ratio
3.4.1 Global Polymyositis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Polymyositis Treatment Revenue in 2022
3.5 Polymyositis Treatment Key Players Head office and Area Served
3.6 Key Players Polymyositis Treatment Product Solution and Service
3.7 Date of Enter into Polymyositis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Polymyositis Treatment Breakdown Data by Type
4.1 Global Polymyositis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Polymyositis Treatment Forecasted Market Size by Type (2024-2033)
5 Polymyositis Treatment Breakdown Data by Application
5.1 Global Polymyositis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Polymyositis Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Polymyositis Treatment Market Size (2018-2033)
6.2 North America Polymyositis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Polymyositis Treatment Market Size by Country (2018-2023)
6.4 North America Polymyositis Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Polymyositis Treatment Market Size (2018-2033)
7.2 Europe Polymyositis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Polymyositis Treatment Market Size by Country (2018-2023)
7.4 Europe Polymyositis Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Polymyositis Treatment Market Size (2018-2033)
8.2 Asia-Pacific Polymyositis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Polymyositis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Polymyositis Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Polymyositis Treatment Market Size (2018-2033)
9.2 Latin America Polymyositis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Polymyositis Treatment Market Size by Country (2018-2023)
9.4 Latin America Polymyositis Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Polymyositis Treatment Market Size (2018-2033)
10.2 Middle East & Africa Polymyositis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Polymyositis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Polymyositis Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hospira, Inc.
11.1.1 Hospira, Inc. Company Detail
11.1.2 Hospira, Inc. Business Overview
11.1.3 Hospira, Inc. Polymyositis Treatment Introduction
11.1.4 Hospira, Inc. Revenue in Polymyositis Treatment Business (2018-2023)
11.1.5 Hospira, Inc. Recent Development
11.2 Antares Pharma, Inc.
11.2.1 Antares Pharma, Inc. Company Detail
11.2.2 Antares Pharma, Inc. Business Overview
11.2.3 Antares Pharma, Inc. Polymyositis Treatment Introduction
11.2.4 Antares Pharma, Inc. Revenue in Polymyositis Treatment Business (2018-2023)
11.2.5 Antares Pharma, Inc. Recent Development
11.3 Medexus Pharma, Inc.
11.3.1 Medexus Pharma, Inc. Company Detail
11.3.2 Medexus Pharma, Inc. Business Overview
11.3.3 Medexus Pharma, Inc. Polymyositis Treatment Introduction
11.3.4 Medexus Pharma, Inc. Revenue in Polymyositis Treatment Business (2018-2023)
11.3.5 Medexus Pharma, Inc. Recent Development
11.4 Fresenius SE & Co. KGaA
11.4.1 Fresenius SE & Co. KGaA Company Detail
11.4.2 Fresenius SE & Co. KGaA Business Overview
11.4.3 Fresenius SE & Co. KGaA Polymyositis Treatment Introduction
11.4.4 Fresenius SE & Co. KGaA Revenue in Polymyositis Treatment Business (2018-2023)
11.4.5 Fresenius SE & Co. KGaA Recent Development
11.5 Mylan N.V.
11.5.1 Mylan N.V. Company Detail
11.5.2 Mylan N.V. Business Overview
11.5.3 Mylan N.V. Polymyositis Treatment Introduction
11.5.4 Mylan N.V. Revenue in Polymyositis Treatment Business (2018-2023)
11.5.5 Mylan N.V. Recent Development
11.6 Alcami Corporation
11.6.1 Alcami Corporation Company Detail
11.6.2 Alcami Corporation Business Overview
11.6.3 Alcami Corporation Polymyositis Treatment Introduction
11.6.4 Alcami Corporation Revenue in Polymyositis Treatment Business (2018-2023)
11.6.5 Alcami Corporation Recent Development
11.7 Teva Pharmaceuticals
11.7.1 Teva Pharmaceuticals Company Detail
11.7.2 Teva Pharmaceuticals Business Overview
11.7.3 Teva Pharmaceuticals Polymyositis Treatment Introduction
11.7.4 Teva Pharmaceuticals Revenue in Polymyositis Treatment Business (2018-2023)
11.7.5 Teva Pharmaceuticals Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Detail
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Polymyositis Treatment Introduction
11.8.4 Novartis AG Revenue in Polymyositis Treatment Business (2018-2023)
11.8.5 Novartis AG Recent Development
11.9 Genentech, Inc.
11.9.1 Genentech, Inc. Company Detail
11.9.2 Genentech, Inc. Business Overview
11.9.3 Genentech, Inc. Polymyositis Treatment Introduction
11.9.4 Genentech, Inc. Revenue in Polymyositis Treatment Business (2018-2023)
11.9.5 Genentech, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Polymyositis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Immunosuppressant
Table 3. Key Players of Alkylating Agent
Table 4. Key Players of Immunoglobulin
Table 5. Key Players of Monoclonal Antibodies
Table 6. Key Players of Corticosteroids
Table 7. Global Polymyositis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Polymyositis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Polymyositis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Polymyositis Treatment Market Share by Region (2018-2023)
Table 11. Global Polymyositis Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Polymyositis Treatment Market Share by Region (2024-2033)
Table 13. Polymyositis Treatment Market Trends
Table 14. Polymyositis Treatment Market Drivers
Table 15. Polymyositis Treatment Market Challenges
Table 16. Polymyositis Treatment Market Restraints
Table 17. Global Polymyositis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Polymyositis Treatment Market Share by Players (2018-2023)
Table 19. Global Top Polymyositis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polymyositis Treatment as of 2022)
Table 20. Ranking of Global Top Polymyositis Treatment Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Polymyositis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Polymyositis Treatment Product Solution and Service
Table 24. Date of Enter into Polymyositis Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Polymyositis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Polymyositis Treatment Revenue Market Share by Type (2018-2023)
Table 28. Global Polymyositis Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Polymyositis Treatment Revenue Market Share by Type (2024-2033)
Table 30. Global Polymyositis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Polymyositis Treatment Revenue Market Share by Application (2018-2023)
Table 32. Global Polymyositis Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Polymyositis Treatment Revenue Market Share by Application (2024-2033)
Table 34. North America Polymyositis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Polymyositis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Polymyositis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Polymyositis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Polymyositis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Polymyositis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Polymyositis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Polymyositis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Polymyositis Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Polymyositis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Polymyositis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Polymyositis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Polymyositis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Polymyositis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Polymyositis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 49. Hospira, Inc. Company Detail
Table 50. Hospira, Inc. Business Overview
Table 51. Hospira, Inc. Polymyositis Treatment Product
Table 52. Hospira, Inc. Revenue in Polymyositis Treatment Business (2018-2023) & (US$ Million)
Table 53. Hospira, Inc. Recent Development
Table 54. Antares Pharma, Inc. Company Detail
Table 55. Antares Pharma, Inc. Business Overview
Table 56. Antares Pharma, Inc. Polymyositis Treatment Product
Table 57. Antares Pharma, Inc. Revenue in Polymyositis Treatment Business (2018-2023) & (US$ Million)
Table 58. Antares Pharma, Inc. Recent Development
Table 59. Medexus Pharma, Inc. Company Detail
Table 60. Medexus Pharma, Inc. Business Overview
Table 61. Medexus Pharma, Inc. Polymyositis Treatment Product
Table 62. Medexus Pharma, Inc. Revenue in Polymyositis Treatment Business (2018-2023) & (US$ Million)
Table 63. Medexus Pharma, Inc. Recent Development
Table 64. Fresenius SE & Co. KGaA Company Detail
Table 65. Fresenius SE & Co. KGaA Business Overview
Table 66. Fresenius SE & Co. KGaA Polymyositis Treatment Product
Table 67. Fresenius SE & Co. KGaA Revenue in Polymyositis Treatment Business (2018-2023) & (US$ Million)
Table 68. Fresenius SE & Co. KGaA Recent Development
Table 69. Mylan N.V. Company Detail
Table 70. Mylan N.V. Business Overview
Table 71. Mylan N.V. Polymyositis Treatment Product
Table 72. Mylan N.V. Revenue in Polymyositis Treatment Business (2018-2023) & (US$ Million)
Table 73. Mylan N.V. Recent Development
Table 74. Alcami Corporation Company Detail
Table 75. Alcami Corporation Business Overview
Table 76. Alcami Corporation Polymyositis Treatment Product
Table 77. Alcami Corporation Revenue in Polymyositis Treatment Business (2018-2023) & (US$ Million)
Table 78. Alcami Corporation Recent Development
Table 79. Teva Pharmaceuticals Company Detail
Table 80. Teva Pharmaceuticals Business Overview
Table 81. Teva Pharmaceuticals Polymyositis Treatment Product
Table 82. Teva Pharmaceuticals Revenue in Polymyositis Treatment Business (2018-2023) & (US$ Million)
Table 83. Teva Pharmaceuticals Recent Development
Table 84. Novartis AG Company Detail
Table 85. Novartis AG Business Overview
Table 86. Novartis AG Polymyositis Treatment Product
Table 87. Novartis AG Revenue in Polymyositis Treatment Business (2018-2023) & (US$ Million)
Table 88. Novartis AG Recent Development
Table 89. Genentech, Inc. Company Detail
Table 90. Genentech, Inc. Business Overview
Table 91. Genentech, Inc. Polymyositis Treatment Product
Table 92. Genentech, Inc. Revenue in Polymyositis Treatment Business (2018-2023) & (US$ Million)
Table 93. Genentech, Inc. Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Polymyositis Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Polymyositis Treatment Market Share by Type: 2022 VS 2033
Figure 3. Immunosuppressant Features
Figure 4. Alkylating Agent Features
Figure 5. Immunoglobulin Features
Figure 6. Monoclonal Antibodies Features
Figure 7. Corticosteroids Features
Figure 8. Global Polymyositis Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Polymyositis Treatment Market Share by Application: 2022 VS 2033
Figure 10. Hospitals Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Polymyositis Treatment Report Years Considered
Figure 14. Global Polymyositis Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Polymyositis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Polymyositis Treatment Market Share by Region: 2022 VS 2033
Figure 17. Global Polymyositis Treatment Market Share by Players in 2022
Figure 18. Global Top Polymyositis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polymyositis Treatment as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Polymyositis Treatment Revenue in 2022
Figure 20. North America Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Polymyositis Treatment Market Share by Country (2018-2033)
Figure 22. United States Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Polymyositis Treatment Market Share by Country (2018-2033)
Figure 26. Germany Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Polymyositis Treatment Market Share by Region (2018-2033)
Figure 34. China Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Polymyositis Treatment Market Share by Country (2018-2033)
Figure 42. Mexico Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Polymyositis Treatment Market Share by Country (2018-2033)
Figure 46. Turkey Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Polymyositis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Hospira, Inc. Revenue Growth Rate in Polymyositis Treatment Business (2018-2023)
Figure 49. Antares Pharma, Inc. Revenue Growth Rate in Polymyositis Treatment Business (2018-2023)
Figure 50. Medexus Pharma, Inc. Revenue Growth Rate in Polymyositis Treatment Business (2018-2023)
Figure 51. Fresenius SE & Co. KGaA Revenue Growth Rate in Polymyositis Treatment Business (2018-2023)
Figure 52. Mylan N.V. Revenue Growth Rate in Polymyositis Treatment Business (2018-2023)
Figure 53. Alcami Corporation Revenue Growth Rate in Polymyositis Treatment Business (2018-2023)
Figure 54. Teva Pharmaceuticals Revenue Growth Rate in Polymyositis Treatment Business (2018-2023)
Figure 55. Novartis AG Revenue Growth Rate in Polymyositis Treatment Business (2018-2023)
Figure 56. Genentech, Inc. Revenue Growth Rate in Polymyositis Treatment Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed